Fintel reports that on December 15, 2025, Wells Fargo maintained coverage of Thermo Fisher Scientific (NYSE:TMO) with a ...

Thermo Fisher Scientific Inc. has introduced Gibco Bacto CD Supreme FPM Plus and Gibco Bacto CD Supreme Feed (2X).

The new Gibco™ Bacto™ CD Supreme FPM Plus and Feed (2X) address these needs by simplifying E. coli bioprocessing workflows and delivering predictable, high-quality results. Engineered to deliver ...

According to The Fly, on December 2, 2025, Morgan Stanley analyst Kallum Titchmarsh established a price objective of $670, up from $656. He initiated coverage of Thermo Fisher Scientific Inc.

According to editorialists, the study has the potential for major clinical impact, but more work is needed before guidelines ...

Read here for an analysis of Solventum (SOLV) stock's growth potential with disciplined reinvestment, cost-saving initiatives ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $390.0 to $560.0 for Thermo Fisher Scientific over the recent three months.

Pranshi Mehta is representing the state of Texas after being named the first-place science winner at the 2025 Thermo Fisher ...

The global Proteomics Market is on a rapid growth trajectory, projected to reach USD 134.82 billion by 2035 from an estimated USD 44.79 billion in 2025, reflecting a robust CAGR of 11.7%. Driven by ...

The global Molecular Spectroscopy Market is poised for remarkable growth, projected to nearly double from USD 7.3 billion in ...

Fintel reports that on December 9, 2025, Goldman Sachs initiated coverage of Thermo Fisher Scientific (NYSE:TMO) with a Buy recommendation. Analyst Price Forecast Suggests 11.10% Upside As of December ...